GLUT1 as a generic biomarker enables near-infrared fluorescence molecular imaging guided precise intraoperative tumor detection in breast cancer
- 21 January 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (6) , 2171-2186
Abstract
Purpose Precise tumor excision is important but challenging in breast-conserving surgery (BCS). Tumor-specific fluorescence imaging may be used for intraoperative tumor detection and, therefore, to guide precise tumor excision. The aims of this study are to develop a glucose transporter 1 (GLUT1)-targeted near-infrared fluorescence tracer and evaluate its accuracy for breast cancer detection using fresh surgical breast specimens. Methods Bioinformatic analysis was performed to compare GLUT1 expression between breast cancer and normal breast tissues. A GLUT1-targeted fluorescence imaging tracer WZB117-CY7.5 was developed. In combination with fluorescence imaging (FMI), its binding specificity to GLUT1 was examined in in vitro breast cancer cell experiments, in vivo 4T1 breast tumor-bearing mouse models, and 60 freshly resected human breast tumor tissues. The diagnostic accuracy of WZB117-CY7.5, was evaluated in fresh specimens derived from 60 patients diagnosed with breast cancer. Results GLUT1 expression is higher in breast cancer tissues compared with normal tissues. WZB117-CY7.5 specifically bound to breast cancer cells in in vitro cell experiments and accumulated in tumor areas in a 4T1 tumor-bearing mice after intravenous injection by FMI. Moreover, WZB117-CY7.5 specifically bound to freshly resected human breast cancer and demonstrated excellent diagnostic performance in discriminating breast cancer, irrespective of cancer subtype, from normal breast tissue on fresh surgically resected breast tissues. Conclusions WZB117-CY7.5 showed high accuracy in intraoperative breast cancer detection, irrespective of the cancer subtype. This highlights its potential for clinical applications as a generic tracer for fluorescence image-guided surgery (FIGS) in BCS and fluorescence image-guided pathology for tissue sampling.Keywords
Funding Information
- Science and Technology Innovation Strategy Special Project of Guangdong Province City and County Science and Technology Innovation Support (STKJ2023006)
- Natural Science Foundation Committee (82372032, 82272111, 92159303, 62027901)
- National Key R&D Program of China (2023YFC3402800)
- Science and technology projects of Shantou (200601155261081, 220509126493383)
- Guangdong Thoracic Cancer Prevention and Treatment Research Society (GASTO-10110)
This publication has 33 references indexed in Scilit:
- Supra‐Fluorophores: Ultrabright Fluorescent Supramolecular Assemblies Derived from Conventional Fluorophores in WaterAdvanced Materials, 2024
- Anti-photobleaching cyanine-based nanoparticles with simultaneous PET and ACQ effects for improved tumor photothermal therapyChemical Engineering Journal, 2022
- Biodegradable Nanoprobe for NIR‐II Fluorescence Image‐Guided Surgery and Enhanced Breast Cancer Radiotherapy EfficacyAdvanced Science, 2022
- Imaging strategies using cyanine probes and materials for biomedical visualization of live animalsCoordination Chemistry Reviews, 2021
- Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast CancerJAMA Oncology, 2016
- Association of Breast Conservation Surgery for Cancer With 90-Day Reoperation Rates in New York StateJAMA Surgery, 2016
- The Emerging Hallmarks of Cancer MetabolismCell Metabolism, 2016
- Repeat Surgery After Breast Conservation for the Treatment of Stage 0 to II Breast CarcinomaJAMA Surgery, 2014
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Novel inhibitors of basal glucose transport as potential anticancer agentsBioorganic & Medicinal Chemistry Letters, 2010